CVE-2022-3716
Published: 27 October 2022
Summary
CVE-2022-3716 is a low-severity Improper Neutralization (CWE-707) vulnerability in Oretnom23 Online Medicine Ordering System. Its CVSS base score is 3.5 (Low).
Operationally, ranked at the 45.3th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2022-43073
Vulnerability details
A vulnerability classified as problematic was found in SourceCodester Online Medicine Ordering System 1.0. Affected by this vulnerability is an unknown functionality of the file /omos/admin/?page=user/list. The manipulation of the argument First Name/Middle Name/Last Name leads to cross site scripting.…
more
The attack can be launched remotely. The associated identifier of this vulnerability is VDB-212347.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Enforces use of documented standards and tool configurations that address proper neutralization of inputs/outputs during development.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.